These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 20385531)

  • 1. Confocal biomicroscopy of corneal intraepithelial neoplasia regression following interferon alpha 2b treatment.
    Gabison EE; Labbé A; Brignole-Baudouin F; Nourry H; Putterman M; Malecaze F; Hoang-Xuan T; Baudouin C
    Br J Ophthalmol; 2010 Jan; 94(1):134-5. PubMed ID: 20385531
    [No Abstract]   [Full Text] [Related]  

  • 2. Recurrent intraepithelial neoplasia treatment.
    Schechter BA; Nagler RS; Schrier A
    Ophthalmology; 2005 Jul; 112(7):1319; author reply 1319. PubMed ID: 15993243
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b.
    Boehm MD; Huang AJ
    Ophthalmology; 2004 Sep; 111(9):1755-61. PubMed ID: 15350333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Topical interferon alfa-2b or surgical excision for primary treatment of conjunctiva-cornea intraepithelial neoplasia].
    Huerva V
    Arch Soc Esp Oftalmol; 2009 Jan; 84(1):5-6. PubMed ID: 19173133
    [No Abstract]   [Full Text] [Related]  

  • 5. Anterior segment OCT and confocal microscopy findings in atypical corneal intraepithelial neoplasia.
    Chin EK; Cortés DE; Lam A; Mannis MJ
    Cornea; 2013 Jun; 32(6):875-9. PubMed ID: 23538623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of conjunctival and corneal intraepithelial neoplasia treated with topical interferon alfa-2b.
    Schechter BA; Koreishi AF; Karp CL; Feuer W
    Ophthalmology; 2008 Aug; 115(8):1291-6, 1296.e1. PubMed ID: 18187195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment with 5-Fu.
    Schechter BA; Nagler RS
    Ophthalmology; 2003 Jun; 110(6):1262-3; author reply 1263. PubMed ID: 12799258
    [No Abstract]   [Full Text] [Related]  

  • 8. Topical Interferon Alpha-2b Induced Reactive Lymphoid Hyperplasia Masquerading as Orbital Extension of Ocular Surface Squamous Neoplasia.
    Lee GA; Hess L; Glasson WJ; Whitehead K
    Cornea; 2018 Jun; 37(6):796-798. PubMed ID: 29489517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment with 5-Fu.
    Schechter BA; Nagler RS
    Ophthalmology; 2003 Apr; 110(4):625-6; author reply 626. PubMed ID: 12689863
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of CIN with retinoic acid and topical interferon alfa-2b.
    Huerva V
    Ophthalmology; 2013 Aug; 120(8):e55. PubMed ID: 23916085
    [No Abstract]   [Full Text] [Related]  

  • 11. Regression of presumed primary conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b.
    Schechter BA; Schrier A; Nagler RS; Smith EF; Velasquez GE
    Cornea; 2002 Jan; 21(1):6-11. PubMed ID: 11805499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b.
    Karp CL; Moore JK; Rosa RH
    Ophthalmology; 2001 Jun; 108(6):1093-8. PubMed ID: 11382635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia.
    Vann RR; Karp CL
    Ophthalmology; 1999 Jan; 106(1):91-7. PubMed ID: 9917787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Author reply: To PMID 22704834.
    Coroneo M
    Ophthalmology; 2013 Aug; 120(8):e55-6. PubMed ID: 23916086
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumor-volume increase at beginning of primary treatment with topical interferon alpha 2-beta in a case of conjunctiva-cornea intraepithelial neoplasia.
    Huerva V; Sánchez MC; Mangues I
    J Ocul Pharmacol Ther; 2007 Apr; 23(2):143-5. PubMed ID: 17444802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical interferon alfa-2b for the treatment of recalcitrant ocular surface squamous neoplasia.
    Holcombe DJ; Lee GA
    Am J Ophthalmol; 2006 Oct; 142(4):568-71. PubMed ID: 17011846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid response of refractory ocular surface dysplasia to combination treatment with topical all-trans retinoic acid and interferon alfa-2b.
    Skippen B; Tsang HH; Assaad NN; Coroneo MT
    Arch Ophthalmol; 2010 Oct; 128(10):1368-9. PubMed ID: 20938011
    [No Abstract]   [Full Text] [Related]  

  • 18. Interferon alpha 2b treatment for residual ocular surface squamous neoplasia unresponsive to excision, cryotherapy and mitomycin-C.
    Nemet AY; Sharma V; Benger R
    Clin Exp Ophthalmol; 2006; 34(4):375-7. PubMed ID: 16764660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical medical therapies for ocular surface tumors.
    Poothullil AM; Colby KA
    Semin Ophthalmol; 2006; 21(3):161-9. PubMed ID: 16912014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia.
    Sturges A; Butt AL; Lai JE; Chodosh J
    Ophthalmology; 2008 Aug; 115(8):1297-302, 1302.e1. PubMed ID: 18294690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.